| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.2M | +2.3% | +1635.2% |
| Cost of Revenue | $5.5M | -11.8% | +1775.6% |
| Gross Profit | $2.7M | +52.1% | +1405.0% |
| R&D Expense | $11.1M | -6.3% | -9.1% |
| SG&A Expense | $519.2M | +2205.3% | +2950.5% |
| Operating Income | -$538.4M | -1149.8% | -1212.7% |
| Pre-tax Income | -$532.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $407.6M | +36.9% | +265.1% |
| Short-term Investments | $284.2M | +131.0% | +531.6% |
| Accounts Receivable | $15.2M | +18.7% | +91.9% |
| Current Assets | $719.8M | +62.6% | +298.7% |
| Total Assets | $883.1M | +45.6% | +248.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$255.9M | — | — |
| Capital Expenditures | $141K | — | — |
| Investing Cash Flow | -$306.3M | — | — |
| Financing Cash Flow | $568.3M | — | — |
| Free Cash Flow | -$256.0M | — | — |
| -1316.3% |
| -1069.6% |
| Net Income | -$273.3M | -1449.3% | -1465.5% |
| EPS (Basic) | -$1.85 | -1323.1% | -927.8% |
| EPS (Diluted) | -$1.85 | -1323.1% | -927.8% |
| $445.6M |
| +324.7% |
| +453.2% |
| Total Liabilities | $448.3M | +316.7% | +174.8% |
| Stockholders' Equity | $828.7M | +19.6% | +417.7% |